Monograph is an institutional investor (Healthcare Startups) founded in 2021 and headquartered in London, United Kingdom. Venture capital firm focused on life sciences companies. It seeks to create improved therapeutics, diagnostics, and related technology-enabled business services that enhance healthcare outcomes. As an institutional investor, the firm manages capital on behalf of institutional limited partners, deploying capital across selected investment opportunities with strong growth potential.

Stage

Seed, Series A, Series B, Series C, Seed, Series A, Series B, Series C

Check size

$3M-$10M

HQ

London, United Kingdom

Founded

2021

Website

https://www.monograph.bio/

LinkedIn

https://linkedin.com/company/monograph-capital

Twitter

http://twitter.com/bamboofinance

What they look for

Innovative companies translating promising science into life-changing treatments; strong teams with expertise bridging research to application; clear path from discovery to patient impact with clinical validation, regulatory strategy, pharma partnerships; primarily North America, UK, Europe

Preparing to pitch Monograph?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.